Associated Papers
Genetic landscape of hereditary cardiomyopathies and arrhythmias in China.
Lu Y et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2026
Integrative structural profiling and ligand optimisation across the transthyretin mutational landscape.
Lomoio U et al.
Npj Systems Biology and Applications, 2025
Etiologic Diagnosis of Neuropathies Based on First-Line Screening of TTR Gene Mutations.
Magot A et al.
Journal of the Peripheral Nervous System : Jpns, 2025
A Multicenter Study of Hereditary Transthyretin Amyloidosis in China.
Chu X et al.
Annals of Neurology, 2025
Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants.
Shetty NS et al.
Nature Communications, 2024
Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Guo H et al.
Annals of Nuclear Medicine, 2024
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
González-Moreno J et al.
Cardiology and Therapy, 2024
RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study.
Beck G et al.
Journal of Neurology, 2023
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Thimm A et al.
Journal of Neurology, 2023
Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan.
Matsushima M et al.
Internal Medicine (tokyo, Japan), 2023
Prevalence estimation of ATTRv in China based on genetic databases.
Yongsheng Z et al.
Frontiers in Genetics, 2023
Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China.
Wang S et al.
Frontiers in Cardiovascular Medicine, 2022
Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation.
Chu X et al.
Frontiers in Molecular Neuroscience, 2022
Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M et al.
Neurologia I Neurochirurgia Polska, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas.
Thimm A et al.
Neurological Research and Practice, 2019
Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T et al.
Journal of the Neurological Sciences, 2017
Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis.
Iorio A et al.
Bmc Genomics, 2017
First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis.
Hagenacker T et al.
Journal of the Neurological Sciences, 2014